Table 2.
Treatment of hypertension and diabetes mellitus according to the control status of both diseases
| Treatment |
Both hypertension and diabetes uncontrolled (n = 208) |
Only diabetes controlled (n = 175) |
Only hypertension controlled (n = 172) |
Both hypertension and diabetes controlled (n = 218) |
P value (ANOVA) |
|---|---|---|---|---|---|
| Treatment of hypertension, n (%) | |||||
| Monotherapy | 126 (60.6) | 103 (58.9) | 98 (57.0) | 128 (58.7) | .92 |
| Combination therapy | 82 (39.4) | 72 (41.1) | 74 (43.0) | 90 (41.3) | .92 |
| Use of RAS inhibitors | 124 (59.6) | 103 (58.9) | 114 (66.3) | 135 (61.9) | .48 |
| Treatment of diabetes mellitus, n (%) | |||||
| Oral antidiabetic drugs alone | 105 (50.5) | 134 (76.6) | 95 (55.2) | 180 (82.6) | <.0001 |
| Insulin alone | 40 (19.2) | 23 (13.1) | 32 (18.6) | 21 (9.6) | .02 |
| Oral antidiabetic drugs plus insulin | 61 (29.3) | 17 (9.7) | 44 (25.6) | 14 (6.4) | <.0001 |
Abbreviation: RAS, renin‐angiotensin system.
Values are number of subjects (%).
For further explanations, see Table 1.